RIMPOVIZ Trademark
Serial Number: 97418690
RIMPOVIZ is a trademark filed by
BIOGEN MA INC.
on May 19, 2022. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently no longer active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Douglas A. Rettew FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LL
901 NEW YORK AVENUE NW
WASHINGTON, DC 20001
UNITED STATES
Trademark Details
Filing Date
May 19, 2022
Registration Date
Not Registered
Published for Opposition
January 17, 2023
Goods & Services
Pharmaceutical preparations for the treatment of eye diseases, disorders, and conditions; ophthalmologic pharmaceutical preparations
Filing History
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 21, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 21, 2024 ABN6
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 30, 2024 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 30, 2023 EXRA
SOU EXTENSION 2 GRANTED
Nov 29, 2023 EX2G
SOU EXTENSION 2 FILED
Nov 29, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 29, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 22, 2023 EXRA
SOU EXTENSION 1 GRANTED
Aug 18, 2023 EX1G
SOU EXTENSION 1 FILED
Aug 18, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 18, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 14, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 17, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 17, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 28, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 12, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 12, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 12, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 12, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 12, 2022 CNEA
ASSIGNED TO EXAMINER
Dec 7, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 25, 2022 NWOS
NEW APPLICATION ENTERED
May 23, 2022 NWAP
